prophylactic erythropoieti

Not Applicable

• Conditions: Haematological Disorders; anemia in critically ill patients

• Registration Number: PACTR201803003169385
• Lead Sponsor: Asmaa Fawzy Amer

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-03-07
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Critically ill patients
aged more than 18 y
of both sex
who can tolerate enteral feeding with full-calorie within 48 hours after admission to ICU
with Hematocrit more than 38%,
without vit B12 , folate ,iron deficiency at time of admission

Exclusion Criteria

Pregnancy or lactation,
Active bleeding,
Presence of any primary hematologic disease.
Subjects prohibited from receiving blood transfusions.
Recent thromboembolic disease (within 6 months)
Chronic renal failure .
Liver failure .
Recent cytotoxic or immunosuppressive therapy (within 1 month).
patients who cannot tolerate enteral feeding throughout period of study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence of anemia in intervention group after prophylactic erythropoietin

Secondary Outcome Measures

Name	Time	Method
rate of blood transfusion in both group ;length of ICU stay;morbidity rate ;mortality rate